by Mybiogate | Nov 17, 2020 | Chinese company profile
Qilu Pharmaceutical 2019 Revenue: US$ 3.3 billion Number of Employees: 2,3000+ Founded: 1992 Overview Qilu Pharmaceutical is one of the leading vertically integrated pharmaceutical companies in China, focusing on the development, manufacturing, and marketing of... by Mybiogate | Nov 17, 2020 | Industry Research
Author: Ginger Ding Following PD-(L)1, high-end players have quickly joined the race to develop the new star T cell immunoreceptors with immunoglobulin and ITIM domain (TIGIT). Roche, BMS, Merck and other international pharmaceutical companies have all entered.... by Mybiogate | Nov 13, 2020 | Industry Research
Author: MJ Yuan Part 2 of a series on the Analgesic Drug Market. Part 1 focused on China while Part 2 takes a global perspective. Opioid Abuse is a Serious Problem, A New Trend in Non-Opioid Medication Begins In 1996, Purdue Pharmaceuticals, run by the Sackler... by Mybiogate | Nov 12, 2020 | Chinese company profile
Luye Pharma Group 2019 Revenue: US$ 0.96 Billion Number of Employees: 4,716 Founded: 1994 Overview Luye Pharma Group, a member of Luye Life Sciences Group, is an international pharmaceutical company focusing on drugs targeting the central nervous system (CNS),... by Mybiogate | Nov 10, 2020 | Industry Research
Author: Ginger Ding “Reflections on CRISPR’s Potential (Part 1)” explores the bottlenecks and challenges of CRISPR clinical applications and uses the case study of CRISPR Therapeutics and Editas to interpret the corporate strategies of different...